Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small bruise at the injection site after Mounjaro is common and, in most cases, nothing to worry about. Bruising happens when the needle nicks a tiny blood vessel just under the skin; it usually fades within a few days and does not affect how well the medicine works. That said, understanding why it happens puts you in a better position to reduce it. These are prescription-only injections, so any technique questions or persistent skin reactions should always be discussed with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most bruising traces back to a blood vessel being clipped by the needle tip. This is more likely when the injection is given too quickly, when the needle enters at an awkward angle, or when the same small patch of skin is used week after week. Rotating between your abdomen, thigh and upper arm matters more than many people realise; returning to a spot that is still tender from the previous injection gives it less chance to recover and raises the risk of bruising again.
Speed is worth thinking about too. Pressing the plunger very briskly means the liquid dispenses fast, which can create localised pressure and contribute to that purple mark. A slow, steady thumb on the button and holding the pen in place for a full ten seconds afterwards before withdrawing gives tissue time to absorb the dose without forcing it against a vessel wall.
Needle depth is a related consideration. If you are injecting too deep or catching muscle rather than subcutaneous fat, a bruise after a Mounjaro injection is a likely result. Our page on whether it is possible to inject Mounjaro too deep covers this in detail, including how to judge the right depth for different body areas. The NHS tirzepatide guidance also recommends rotating sites and following the Patient Information Leaflet closely for injection steps.
A few small adjustments can make a real difference. First, let the pen sit at room temperature for twenty to thirty minutes before injecting; cold liquid straight from the fridge is thicker and requires more force to dispense, which can stress the surrounding tissue. Second, make sure the skin is fully dry before you inject: alcohol from a swab that has not yet evaporated can sting and cause a brief vessel response. If you use alcohol swabs to clean the site, wait ten to fifteen seconds before picking up the pen.
After the injection, apply light pressure with a clean finger or a piece of gauze for thirty seconds. Do not rub; rubbing spreads whatever small bleed has started. Some people find that pinching a small fold of skin before injecting helps lift subcutaneous fat away from muscle, reducing the chance of going too deep. Check your technique against the instructions in the box each time, rather than relying on habit.
If you want a step-by-step walkthrough of the full process, our guide to Mounjaro injection technique covers everything from pen preparation to aftercare. Practical tips for specifically avoiding bruises are also pulled together on the how to inject Mounjaro without bruising page.
Most injection bruises are small, flat, and gone within a week. They look worse on day two than day one, then fade through green and yellow before clearing. That pattern is normal. What is less normal: a bruise that is spreading rather than shrinking after 48 hours, a lump underneath the skin that is getting harder or more painful, bruising that appears in places you have not injected, or any sign of infection such as increasing warmth, redness beyond the bruise edge, or discharge.
If you are taking blood thinners (anticoagulants such as warfarin or apixaban) or aspirin regularly, bruising at injection sites is likely to be more pronounced; your prescriber needs to know this at consultation, as it influences technique advice and what to watch for. The MHRA's Yellow Card scheme exists for reporting unexpected or concerning reactions to any medicine, including injection-site effects you think should be on the record.
A question our prescribers hear fairly regularly is whether bruising means the dose did not absorb properly. It does not. A bruise is a surface capillary bleed; the tirzepatide in the pen has already dispersed into the subcutaneous tissue. More detail on what affects absorption is covered in the Mounjaro bruising at injection site guide.
If bruising is making you anxious about each weekly injection, it is worth pausing to consider the bigger picture of your treatment plan. Mounjaro is a prescription medicine requiring ongoing clinical oversight; that is not just a formality. A prescriber can review your injection technique, your rotation pattern and your skin responses as part of normal aftercare. At nume, aftercare is included in the price you pay, with prescribers available seven days a week, so concerns like this do not have to sit until your next scheduled check-in. For context on what private Mounjaro treatment typically costs as a whole, our Mounjaro prices page gives a straightforward breakdown. If you want to explore treatment options more broadly, our weight-loss treatment overview is a good starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.